ArticleClinical cancer research : an official journal of the American Association for Cancer Research2014

A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancer.

Graham S Taylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.